Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.3500
-0.0399 (-10.23%)
At close: Feb 18, 2026

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Non-invasive Cervical Cancer Detection Device
98.00K
Non-invasive Cervical Cancer Detection Device Growth
653.85%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
China, Southeast Asia (including Indonesia), Central & Eastern Europe and Saudi Arabia
98.00K
China, Southeast Asia (including Indonesia), Central & Eastern Europe and Saudi Arabia Growth
653.85%